Askel Healthcare has reached an important milestone towards marketing authorization of the COPLA® implant in EU and the USA

Finnish medical technology company Askel Healthcare is developing a new method to treat knee cartilage defects. Askel Healthcare’s COPLA® implant is expected to significantly accelerate rehabilitation and enable healing of damaged knee cartilage. From the beginning of January, COPLA®…